Take a look at the viralytics website.
There are two interesting articles.One by bioshares april 2012
and the other by microcapbookapril 2012.This is a viralytics research overview.
According to the reports professor shafren is very pleased by how the phase 2 trial is progressing.Interpret that
as you wish?finding suitable patients for the trial or is it patients responding to the cavatek injections